Methylphenidate as a treatment option for substance use disorder: a transdiagnostic perspective.

van Ruitenbeek, Peter; Franzen, Luisa; Mason, Natasha Leigh; Stiers, Peter; Ramaekers, Johannes G

van Ruitenbeek, Peter; Franzen, Luisa; Mason, Natasha Leigh; Stiers, Peter; Ramaekers, Johannes G.

Afiliación

van Ruitenbeek P; Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, Netherlands.
Franzen L; Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, Netherlands.
Mason NL; Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, Netherlands.
Stiers P; Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, Netherlands.
Ramaekers JG; Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, Netherlands.

Front Psychiatry ; 14: 1208120, 2023.

Article en En | MEDLINE | ID: mdl-37599874

Palabras clave

addiction; attention deficit hyperactivity disorder; cognitive control; methylphenidate (MPH); psychopharmacology

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Psychiatry Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google